When Novelty and Non-obviousness Aren’t Enough: Meeting the Requirements of Sufficiency, Enablement and Clarity in Chemical and Life Sciences Cases

Achieving a positive assessment of novelty and non-obviousness is an important step en route to achieving a granted patent; however, it is not enough. Your claims and description must also satisfy requirements such as sufficiency, enablement and clarity. In this webinar we discuss these important requirements, comparing and contrasting the approach taken by the USPTO and EPO, and focusing on the issues raised in chemical and life sciences cases.

Topics to be discussed include:

• Support/enablement/sufficiency/plausibility: what are the differences between these requirements and how do you ensure that you have met them all for your chemical and biotechnology cases
• Experimental data: how much and what type is needed such that your invention is enabled, supported, sufficient and plausible?
• Is it possible to avoid clarity issues by careful drafting of your chemical and biotechnology cases, and can you remedy all clarity issues during examination?
  
  

Recorded: View On Demand

 Moderator:
Anthony Tridico

Speakers:
Amanda Murphy
Maeve O’Flynn